Inventor · disambiguated record
Shaomeng Wang
Also filed as: WANG SHAOMENG
78 granted patents·44 pending applications·723 citations·filing 1995–2024
99Inventor score
Files withUNIV MICHIGAN REGENTS50UNIV MICHIGAN30WANG SHAOMENG22UNIV GEORGETOWN4ASCENTAGE PHARMA SUZHOU CO LTD3
Top patents by PatentIndex Score
122 records- 0197US7759383B2Small molecule inhibitors of MDM2 and the uses thereofUNIV MICHIGAN·Filed 2006·Granted Jul 20, 2010·57 cites·9 claims
- 0296US7737174B2Indole inhibitors of MDM2 and the uses thereofUNIV MICHIGAN·Filed 2007·Granted Jun 15, 2010·49 cites·25 claims
- 0394US10307407B29H-pyrimido [4,5-B] indoles as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2016·Granted Jun 4, 2019·11 cites·6 claims
- 0494US10253044B29H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2017·Granted Apr 9, 2019·11 cites·14 claims
- 0594US8691184B2Bcl-2/Bcl-xL inhibitors and therapeutic methods using the sameWANG SHAOMENG·Filed 2012·Granted Apr 8, 2014·42 cites·15 claims
- 0694US8088931B2Small molecule inhibitors of MDM2 and the uses thereofWANG SHAOMENG·Filed 2010·Granted Jan 3, 2012·28 cites·8 claims
- 0794US6703382B2Small molecule inhibitors targeted at Bcl-2UNIV GEORGETOWN MED CENTER·Filed 2001·Granted Mar 9, 2004·81 cites·8 claims
- 0893US7932382B2Conformationally constrained Smac mimetics and the uses thereofUNIV MICHIGAN·Filed 2005·Granted Apr 26, 2011·17 cites·4 claims
- 0992US10221174B2N-(phenylsulfonyl)benzamides and related compounds as BCL-2 inhibitorsUNIV MICHIGAN REGENTS·Filed 2018·Granted Mar 5, 2019·11 cites·9 claims
- 1092US9403856B2Bcl-2/Bcl-xL inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2015·Granted Aug 2, 2016·15 cites·2 claims
- 1192US8222288B2Small molecule inhibitors of MDM2 and the uses thereofWANG SHAOMENG·Filed 2010·Granted Jul 17, 2012·28 cites·16 claims
- 1290US9580430B29H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2015·Granted Feb 28, 2017·7 cites·18 claims
- 1390US7674787B2Conformationally constrained Smac mimetics and the uses thereofUNIV MICHIGAN·Filed 2005·Granted Mar 9, 2010·16 cites·4 claims
- 1489US9675697B2BET bromodomain inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2014·Granted Jun 13, 2017·16 cites·21 claims
- 1589US9096625B2BCL-2/BCL-XL inhibitors and therapeutic methods using the sameUNIV MICHIGAN·Filed 2014·Granted Aug 4, 2015·18 cites·18 claims
- 1689US8680132B2Spiro-oxindole MDM2 antagonistsWANG SHAOMENG·Filed 2011·Granted Mar 25, 2014·13 cites·7 claims
- 1788US8629141B2Spiro-oxindole MDM2 antagonistsWANG SHAOMENG·Filed 2012·Granted Jan 14, 2014·14 cites·19 claims
- 1888US8445473B2Heteroaryl-substituted bicyclic Smac mimetics and the uses thereofWANG SHAOMENG·Filed 2009·Granted May 21, 2013·14 cites·3 claims
- 1987US10829488B2N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitorsUNIV MICHIGAN REGENTS·Filed 2017·Granted Nov 10, 2020·3 cites·11 claims
- 2087US8557812B2Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereofWANG SHAOMENG·Filed 2005·Granted Oct 15, 2013·9 cites·7 claims
- 2187US8518984B2Spiro-oxindole MDM2 antagonistsWANG SHAOMENG·Filed 2010·Granted Aug 27, 2013·11 cites·37 claims
- 2287US7354928B2Small molecule inhibitors targeted at Bcl-2UNIV MICHIGAN·Filed 2002·Granted Apr 8, 2008·22 cites·20 claims
- 2387US7355015B1Matriptase, a serine protease and its applicationsGEORGETOWN UNIVERSITY SCHOOL O·Filed 2000·Granted Apr 8, 2008·27 cites·7 claims
- 2487US7342046B2Gossypol co-crystals and the use thereofUNIV MICHIGAN·Filed 2005·Granted Mar 11, 2008·10 cites·13 claims
- 2586US8742121B2Process for the preparation of small molecule inhibitors of MDM2 and intermediates used thereinWANG SHAOMENG·Filed 2012·Granted Jun 3, 2014·3 cites·16 claims
- 2686US7960372B2Bivalent Smac mimetics and the uses thereofUNIV MICHIGAN·Filed 2007·Granted Jun 14, 2011·14 cites·13 claims
- 2786US7268115B2Peptidomimetic modulators of cell adhesionADHEREX TECHNOLOGIES INC·Filed 2003·Granted Sep 11, 2007·11 cites·3 claims
- 2885US10391175B2BET bromodomain inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2017·Granted Aug 27, 2019·6 cites·18 claims
- 2985US8278293B2Diazo bicyclic Smac mimetics and the uses thereofWANG SHAOMENG·Filed 2008·Granted Oct 2, 2012·10 cites·5 claims
- 3085US8202902B2Bivalent SMAC mimetics and the uses thereofWANG SHAOMENG·Filed 2008·Granted Jun 19, 2012·6 cites·4 claims
- 3184US9745314B2MDM2 inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2015·Granted Aug 29, 2017·6 cites·26 claims
- 3284US7432304B2Small molecule antagonists of Bcl-2 family proteinsUNIV MICHIGAN·Filed 2003·Granted Oct 7, 2008·16 cites·37 claims
- 3383US11046703B2Small molecule MDM2 protein degradersUNIV MICHIGAN REGENTS·Filed 2019·Granted Jun 29, 2021·2 cites·18 claims
- 3481US8901117B2Small molecule inhibitors of MDM2 and the uses thereofWANG SHAOMENG·Filed 2011·Granted Dec 2, 2014·2 cites·7 claims
- 3580US9079913B2Spiro-oxindole MDM2 antagonistsUNIV MICHIGAN·Filed 2014·Granted Jul 14, 2015·3 cites·15 claims
- 3680US7910621B2Small molecule antagonists of XIAP family proteinsUNIV MICHIGAN·Filed 2005·Granted Mar 22, 2011·5 cites·22 claims
- 3779US11691989B2Macrocyclic indoles as Mcl-1 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Jul 4, 2023·3 cites·41 claims
- 3879US10759808B2Monofunctional intermediates for ligand-dependent target protein degradationUNIV MICHIGAN REGENTS·Filed 2017·Granted Sep 1, 2020·2 cites·20 claims
- 3979US8883771B2Bivalent inhibitors of IAP proteins and therapeutic methods using the sameUNIV MICHIGAN·Filed 2013·Granted Nov 11, 2014·6 cites·22 claims
- 4079US8815927B2Bivalent diazo bicyclic Smac mimetics and the uses thereofWANG SHAOMENG·Filed 2010·Granted Aug 26, 2014·5 cites·3 claims
- 4178US11192898B2MDM2 protein degradersUNIV MICHIGAN REGENTS·Filed 2017·Granted Dec 7, 2021·1 cites·7 claims
- 4278US8163805B2Small molecule antagonists of Bcl-2 family proteinsWANG SHAOMENG·Filed 2008·Granted Apr 24, 2012·2 cites·20 claims
- 4377US11168082B2Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitorsUNIV MICHIGAN REGENTS·Filed 2018·Granted Nov 9, 2021·2 cites·20 claims
- 4477US2025034162A1Imidazopyrimidines as eed inhibitors and the use thereofUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 4576US5962504ASubstituted 2-pyrrolidinone activators of PKCUNIV GEORGETOWN·Filed 1998·Granted Oct 5, 1999·35 cites·16 claims
- 4675US8877796B2Spiro-oxindole MDM2 antagonistsUNIV MACHIGAN·Filed 2013·Granted Nov 4, 2014·4 cites·23 claims
- 4774US6677377B2Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditionsGEORGETOWN UNIVERSITY SCHOOL O·Filed 2001·Granted Jan 13, 2004·15 cites·23 claims
- 4873US7432300B2Gossypol co-crystals and the use thereofUNIV MICHIGAN·Filed 2007·Granted Oct 7, 2008·1 cites·10 claims
- 4971US11046709B2Fused 1,4-diazepines as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2018·Granted Jun 29, 2021·1 cites·12 claims
- 5070US10899738B2Piperidines as menin inhibitorsUNIV MICHIGAN REGENTS·Filed 2017·Granted Jan 26, 2021·1 cites·29 claims
Showing the top 50 of 122 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shaomeng Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →